Friday, 6 November 2015

International Conference on Cancer Immunology and Immunotherapy

About Conference

OMICS International officially welcomes the scientific community to attend the International Conference on Cancer Immunology and Immunotherapy”, during July 28-30, 2016 in Melbourne, Australia. This conference will focus on the latest and exciting innovations in every area of cancer immunology research, and it will offer a unique and unprecedented opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions.
Cancer Immunology -2016 Conference deals with the diagnosis, prevention, and treatment of diseases of the organ specific cancers and including the latest techniques. Cancer Immunology 2016 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. Head and Neck Cancer The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques. Cancer Immunology 2016 provides three days of robust discussions on methods and strategies related to management and quality improvement of Cancer therapy as well as explore new ideas and concepts on a global scale and the topics include breast cancer, leukemia, bone cancer, lung cancer, prostate cancer, thyroid cancer, blood cancer, colon cancer and cervical cancer.
Target Audience
  • Cancer research  Students, Scientists
  • Cancer research  Researchers
  • Cancer research  Faculty
  • Onclogist
  • Medical Colleges
  • Cancer research  Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Manufacturing Medical Devices Companies

Conference Highlights

  • Cancer Research
  • Cancer Immunology
  • Immunotherapy Monitoring
  • Immune Function Stimulation
  • Novel Approaches
  • Cancer Immunotherapy
  • Antibodies Treatment:Cancer
  • Anti-Cancer Vaccines
  • Adoptive Cell Therapy
  • Engineered T-Cell Therapy
  • Cancer Stem Cell Immunology
  • Oncothermia
  • Immunotherapy in Pediatric Oncology
  • Advances in Cancer Immunotherapy

Special Issues

  •  All accepted abstracts will be published in respective OMICS International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.